Antonios Arapis, Dimitrios Panagiotopoulos, Evangelos J. Giamarellos-Bourboulis

Burns & Trauma, 2025, 13, tkaf001
DOI: 10.1093/burnst/tkaf001Download pdf 🡇

Keywords: Precision immunotherapy; Sepsis; Anakinra; Nangibotide; Nivolumab; Interferon-gamma; Growth factors; Adrecizumab